216 related articles for article (PubMed ID: 35210296)
1. Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
Viveros-Carreño D; Rodriguez J; Rendon Pereira GJ; Slama J; Halaska MJ; Robova H; Pareja R
Int J Gynecol Cancer; 2022 Apr; 32(4):486-493. PubMed ID: 35210296
[TBL] [Abstract][Full Text] [Related]
2. Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
Plaikner A; Siegler K; Hertel H; Jacob A; Petzel A; Schubert M; Blohmer JU; Böhmer G; Marnitz S; Ragosch V; Domröse C; Oppelt P; Jülicher A; Schneider A; Willems A; Favero G; Köhler C
Int J Gynecol Cancer; 2023 Oct; 33(10):1542-1547. PubMed ID: 37696645
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
Burbano J; Heredia F; Sanabria D; Ardila EG; Viveros-Carreño D; Rodriguez J
Int J Gynecol Cancer; 2021 Mar; 31(3):387-398. PubMed ID: 33649006
[TBL] [Abstract][Full Text] [Related]
4. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
[TBL] [Abstract][Full Text] [Related]
5. Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer ≥2 cm.
Rendón GJ; Lopez Blanco A; Aragona A; Saadi JM; Di Guilmi J; Arab Eblen C; Heredia Muñoz F; Pareja R
Int J Gynecol Cancer; 2021 Mar; 31(3):462-467. PubMed ID: 33199429
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.
Gwacham NI; McKenzie ND; Fitzgerald ER; Ahmad S; Holloway RW
Gynecol Oncol; 2021 Sep; 162(3):809-815. PubMed ID: 34130862
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
[TBL] [Abstract][Full Text] [Related]
8. Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature.
Kuznicki ML; Chambers LM; Morton M; Son J; Horowitz M; Crean-Tate KK; Hackett L; Rose PG
J Minim Invasive Gynecol; 2021 Mar; 28(3):513-526.e1. PubMed ID: 33223017
[TBL] [Abstract][Full Text] [Related]
9. FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.
Plante M; van Trommel N; Lheureux S; Oza AM; Wang L; Sikorska K; Ferguson SE; Han K; Amant F
Int J Gynecol Cancer; 2019 Jun; 29(5):969-975. PubMed ID: 31101688
[TBL] [Abstract][Full Text] [Related]
10. Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomy.
Tsubamoto H; Kanazawa R; Inoue K; Ito Y; Komori S; Maeda H; Hirota S
Int J Gynecol Cancer; 2012 Jul; 22(6):1057-62. PubMed ID: 22683943
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study.
de Vincenzo R; Ricci C; Fanfani F; Gui B; Gallotta V; Fagotti A; Ferrandina G; Scambia G
Fertil Steril; 2021 Jan; 115(1):148-156. PubMed ID: 33092819
[TBL] [Abstract][Full Text] [Related]
13. Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates.
van Kol KGG; Vergeldt TFM; Bekkers RLM
Gynecol Oncol; 2019 Dec; 155(3):515-521. PubMed ID: 31606284
[TBL] [Abstract][Full Text] [Related]
14. Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer.
Robova H; Halaska MJ; Pluta M; Skapa P; Matecha J; Lisy J; Rob L
Gynecol Oncol; 2014 Nov; 135(2):213-6. PubMed ID: 25159484
[TBL] [Abstract][Full Text] [Related]
15. Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
Fanfani F; Pedone Anchora L; Di Martino G; Bizzarri N; Di Meo ML; Carbone V; Paderno M; Fedele C; Paniga C; Fagotti A; Landoni F; Scambia G; Buda A
Int J Gynecol Cancer; 2021 Mar; 31(3):452-456. PubMed ID: 33649013
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.
Slama J; Runnebaum IB; Scambia G; Angeles MA; Bahrehmand K; Kommoss S; Fagotti A; Narducci F; Matylevich O; Holly J; Martinelli F; Koual M; Kopetskyi V; El-Balat A; Corrado G; Căpîlna ME; Schröder W; Novàk Z; Shushkevich A; Fricová L; Cibula D
Am J Obstet Gynecol; 2023 Apr; 228(4):443.e1-443.e10. PubMed ID: 36427596
[TBL] [Abstract][Full Text] [Related]
17. International radical trachelectomy assessment: IRTA study.
Salvo G; Ramirez PT; Leitao M; Cibula D; Fotopoulou C; Kucukmetin A; Rendon G; Perrotta M; Ribeiro R; Vieira M; Baiocchi G; Falconer H; Persson J; Wu X; Căpilna ME; Ioanid N; Mosgaard BJ; Berlev I; Kaidarova D; Olawaiye AB; Liu K; Nobre SP; Kocian R; Saso S; Rundle S; Noll F; Tsunoda AT; Palsdottir K; Li X; Ulrikh E; Hu Z; Pareja R
Int J Gynecol Cancer; 2019 Mar; 29(3):635-638. PubMed ID: 30765489
[TBL] [Abstract][Full Text] [Related]
18. Nerve-sparing radical abdominal trachelectomy versus nerve-sparing radical hysterectomy in early-stage (FIGO IA2-IB) cervical cancer: a comparative study on feasibility and outcome.
van Gent MD; van den Haak LW; Gaarenstroom KN; Peters AA; van Poelgeest MI; Trimbos JB; de Kroon CD
Int J Gynecol Cancer; 2014 May; 24(4):735-43. PubMed ID: 24651626
[TBL] [Abstract][Full Text] [Related]
19. Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience.
Slama J; Cerny A; Dusek L; Fischerova D; Zikan M; Kocian R; Germanova A; Cibula D
Gynecol Oncol; 2016 Sep; 142(3):401-4. PubMed ID: 27396943
[TBL] [Abstract][Full Text] [Related]
20. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature.
Bentivegna E; Maulard A; Pautier P; Chargari C; Gouy S; Morice P
Fertil Steril; 2016 Oct; 106(5):1195-1211.e5. PubMed ID: 27430207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
